ReviewCancers2025

Actinium-225/Bismuth-213 as Potential Leaders for Targeted Alpha Therapy: Current Supply, Application Barriers, and Future Prospects.

Mohamed F Nawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.